Germany, Sept. 29 -- Germany based ITF Pharma GmbH, Rovi GmbH, Techdow Pharma Germany GmbH, Venipharm GmbH has secured contract from DAK-Gesundheit for Pharmaceutical Products - Completion of a non -exclusive discount agreement according to Section 130a (8) SGB V for the active ingredient Enoxaparin (exclusively IFE 100 mg N2), ATC B01AB05 for the time 01042025 - 31032027. The value of the contract is not disclosed.
Published by HT Digital Content Services with permission from Pivotal Sources....